Impact of Introducing the Pletaal Assist System on Drug Adherence in Outpatients with Ischaemic Stroke: A Pilot Study

Figures & data

Figure 1 Labeling of the Pletaal Assist System^®, as it appeared to the patients.

Figure 2 Flowchart of timing of patient pill intake along the study.

Table 1 Patient Characteristics and Adherence Rate Before Using the Pletaal Assist System^®

Characteristics (n)		Median Adherence Rate % (Range)	P value
Male (16)	Yes	99.5 (55–100)	0.21
	No	100 (90–100)
Smoking (12)	Yes	98.5 (55–100)	0.19
	No	100 (83–100)
Support by family (5)	Yes	100 (97–100)	0.65
	No	100 (55–100)
Hypertension (20)	Yes	100 (55–100)	0.43
	No	100 (97–100)
Diabetes mellitus (12)	Yes	100 (55–100)	0.60
	No	100 (77–100)
Dyslipidemia (13)	Yes	100 (55–100)	0.69
	No	100 (77–100)

Table 2 Patient Characteristics and Appropriate On-Time Drug Intake During Implementation of the Pletaal Assist System^®

Characteristics (n)		Median Appropriate On-Time Drug Intake Rate % (Range)	P value
Male (8)	Yes	97 (79–100)	0.07
	No	99.5 (94–100)
Smoking (6)	Yes	96 (79–100)	0.03
	No	99 (96–100)
Support by family (2)	Yes	99.5 (98–100)	0.06
	No	97 (79–100)
Hypertension (8)	Yes	98 (79–100)	0.64
	No	98.5 (92–100)
Diabetes mellitus (4)	Yes	98 (84–100)	0.80
	No	97 (79–100)
Dyslipidemia (6)	Yes	98.5 (79–100)	0.29
	No	97 (84–100)

Table 3 Casual Blood Pressure, Low-Density Lipoprotein Cholesterol, and HbA1c of All Patients Before, During, and After the Implementation of the Pletaal Assist System^®

	Before	During	After
SBP (mmHg)	130 (84–174)	132 (106–187)	130 (95–157)
DBP (mmHg)	75 (48–99)	78 (58–96)	77 (58–94)
LDL-C (mg/dL)	87 (52–116)	87.5 (52–131)	93 (44–127)
HbA1c (%)	6.1 (5.3–10.1)	6.1 (5.4–9.4)	6.05 (5.3–10.1)

Note: Values are expressed as median (range).

Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL-C, low-density lipoprotein cholesterol.

Figure 3 The compliance rates before, during, and after the implementation of the Pletaal Assist System^® (n=25 per group). There were no significant differences before, during, and after using the Pletaal Assist System^®.

Figure 4 The compliance rate of patients whose compliance rate was less than 100% before using the Pletaal Assist System^® (n=10 per group). The compliance rate while using the Pletaal Assist System^® was significantly higher than before and after using the Pletaal Assist System^®.

Notes: *p<0.05 during versus before, ^#p<0.05 during versus after.